MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway
De Mello, Ramon Andrade, Aguiar, Pedro Nazareth, Tadokoro, Hakaru, Farias-Vieira, Tállita Meciany, Castelo-Branco, Pedro, de Lima Lopes, Gilberto, Pozza, Daniel HumbertoVolume:
10
Language:
english
Journal:
Journal of Thoracic Disease
DOI:
10.21037/jtd.2018.04.122
Date:
June, 2018
File:
PDF, 110 KB
english, 2018